BA
AMAG

Boston Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Boston Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-144,305
Closed -$5.73M – 771
2015
Q3 		$5.73M Buy
144,305
+122,565
+564% +$7.61M 0.21% 144
2015
Q2 		$1.5M Sell
21,740
-5,549
-20% -$349K 0.06% 242
2015
Q1 		$1.49M Buy
27,289
+12,147
+80% +$579K 0.06% 239
2014
Q4 		$645K Sell
15,142
-1,111
-7% -$40.1K 0.03% 312
2014
Q3 		$519K Buy
+16,253
New +$347K 0.02% 341

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Advisors's AMAG Position: Q4 2015 in Review

Boston Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 144,305 shares — an estimated $5.73M sold.

Boston Advisors first reported a position in AMAG in Q3 2014 and held it in 5 quarters. The position peaked at $5.73M in Q3 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Boston Advisors reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Boston Advisors sold 144,305 AMAG Pharmaceuticals shares in Q4 2015, an estimated $5.73M.
  • Boston Advisors first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • Boston Advisors's AMAG Pharmaceuticals position peaked at $5.73M in Q3 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Boston Advisors's 13F filing for Q4 2015, filed 20 Jan 2016.